SARS-CoV-2 replication and drug discovery

SARS-CoV-2 replication and drug discovery

The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has killed millions of people and continues to wreak havoc across the globe. This sudden and deadly pandemic emphasizes the necessity for anti-viral drug development that can be rapidly...

Full description

Bibliographic Details
Main Authors: Farah Nazir, Arnaud John Kombe Kombe, Zunera Khalid, Shaheen Bibi, Hongliang Zhang, Songquan Wu, Tengchuan Jin
Format: Article
Language:English
Published: Elsevier 2024-10-01
Series:Molecular and Cellular Probes
Subjects:
SARS-CoV-2
COVID-19
Protease inhibitor
3C-like protease (3CLpro)
Main protease (Mpro)
RNA-Dependent RNA-Polymerase (RdRp)
Online Access:http://www.sciencedirect.com/science/article/pii/S0890850824000252

Internet

http://www.sciencedirect.com/science/article/pii/S0890850824000252

Similar Items